That single draw delivers ~1.67 mg GHK-Cu, ~0.33 mg BPC-157 and ~0.33 mg TB-500
Reported side effects (minimal) Most users report zero side effects - Epithalon remarkably well-tolerated Occasional reported effects: Mild injection site reactions (redness, slight swelling) Temporary headache (first 1-2 days) Slight drowsiness initially (adjusting to improved sleep ) Vivid dreams (from enhanced melatonin ) Increased appetite in some (rare) What Epithalon does NOT typically cause: No nausea (unlike GLP-1 agonists ) No GI upset No hormonal disruption No mood changes (may improve mood) No dependency or withdrawal Side effect comparison: Managing minor side effects: Headache: Hydrate well, usually resolves day 2-3 Drowsiness: Inject at bedtime instead of morning Vivid dreams: Enjoy them or reduce dose slightly Injection reactions : Rotate sites, ice after injection See our peptide safety and risks guide and common peptide mistakes to avoid
Effects of intravenously administered vitamin B12 on sleep in the rat
Some people use sublingual delivery (powder held under the tongue briefly before swallowing) but there's no strong evidence this meaningfully improves bioavailability for this compound class
Advanced Dose Not more than 0.04 mg/kg/week initially, up to 0.08 mg/kg/week FDA-labeled weight-based regimen ceiling for adult GH deficiency (Genotropin) [6]
This bidirectional gene modulation profile simultaneously promoting tissue remodeling while suppressing destructive inflammation is unusually broad for a tripeptide and distinguishes GHK-Cu from most single-target peptide ligands in the research literature